Mechanism of action of the sesquiterpene compound helenalin in rhabdomyosarcoma cells
Rhabdomyosarcoma (RMS) is the most frequent soft tissue sarcoma in paediatric patients. Relapsed or refractory RMS shows very low 5-year survival rates, which urgently necessitates new chemotherapy agents. Herein, the sesquiterpene lactone, helenalin, was investigated as a new potential therapeutic...
Main Authors: | Mun, H, Townley, HE |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
MDPI
2021
|
Registos relacionados
-
Mechanism of Action of the Sesquiterpene Compound Helenalin in Rhabdomyosarcoma Cells
Por: Hakmin Mun, et al.
Publicado em: (2021-12-01) -
CD44 and CD221 directed magnetic cubosomes for the targeted delivery of helenalin to rhabdomyosarcoma cells
Por: Mun, H, et al.
Publicado em: (2022) -
Active targeting of rhabdomyosarcoma cells using helenalin-loaded functionalised cubosomes
Por: Mun, HM
Publicado em: (2023) -
NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death
Por: Feng, XiaoLing, et al.
Publicado em: (2013) -
NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death
Por: Lim Chuan, et al.
Publicado em: (2012-07-01)